Prognostic impact of BCL2 and MYC expression and translocation in untreated DLBCL: results from the phase III Goya study

L.H. Sehn, M.Z. Oestergaard, M. Trněný, A. Bosi, M. Egyed, A. Illes, H. Nakamae, S. Opat, M. Topp, F. Zaja, G. Fingerle‐Rowson, G. Lei, T. Nielsen, E.A. Punnoose, M. Rahman, J. Ray, L. Zhang, M. Martelli, U. Vitolo

Abstract

Robust identification and analysis of biomarker subgroups confirm the prognostic importance of DH and BCL2 IHC+, and demonstrate that the prognostic effect of BCL2 IHC+ is independent of COO in DLBCL pts in the GOYA study.